The expression of CD200 and CD23 on B lymphocytes in the pollen season and outside the pollen season in atopic dermatitis patients with and without dupilumab therapy
Main Authors: | Jarmila Čelakovská, Eva Čermáková, Ctirad Andrýs, Petra Boudkova, Jan Krejsek |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Journal of Dermatological Treatment |
Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2024.2305832 |
Similar Items
-
The differences in the count of B lymphocytes in atopic dermatitis patients with and without dupilumab therapy and in healthy subjects in pollen season and out of pollen season
by: Jarmila Čelakovská, et al.
Published: (2024-12-01) -
The changes of leukocytes and T lymphocytes in atopic dermatitis patients with and without dupilumab therapy and in control group in pollen season compared to out of pollen season
by: Jarmila Čelakovská, et al.
Published: (2024-12-01) -
Evaluation of Leukocytes, B and T Lymphocytes, and expression of CD200 and CD23 on B lymphocytes in Patients with Atopic Dermatitis on Dupilumab Therapy—Pilot Study
by: Jarmila Čelakovská, et al.
Published: (2023-04-01) -
The association between eosinophils (CD16+ eosinophils), basophils (CD203+ basophils), and CD23 B lymphocytes in patients with atopic dermatitis on dupilumab therapy: pilot study
by: Jarmila Čelakovská, et al.
Published: (2023-04-01) -
The association between the level of specific IgE to molecular components of mites and the expression of CD23 molecule on B lymphocytes in atopic dermatitis patients treated or not treated with dupilumab—Pilot study
by: Jarmila Čelakovská, et al.
Published: (2023-07-01)